source
- Cellares signs first Asian manufacturing deal with Taiwan's GenomeFrontier Therapeutics for CAR-T productionCellares announced a new partnership with Taiwanese biotech GenomeFrontier Therapeutics, marking the manufacturer’s first collaboration in Asia. The agreement will see Cellares evaluate and potenti…
- Goa Therapeutics launches with $15.5M funding to develop fast-acting alcohol sobering drugGoa Therapeutics announced its launch, backed by $15.5 million raised mainly from individual industry leaders, and has filed for an initial public offering that could raise up to $75 million. The…